Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does REGORAFENIB\REGORAFENIB Cause Off label use? 40 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Off label use have been filed in association with REGORAFENIB\REGORAFENIB. This represents 37.7% of all adverse event reports for REGORAFENIB\REGORAFENIB.

40
Reports of Off label use with REGORAFENIB\REGORAFENIB
37.7%
of all REGORAFENIB\REGORAFENIB reports
4
Deaths
22
Hospitalizations

How Dangerous Is Off label use From REGORAFENIB\REGORAFENIB?

Of the 40 reports, 4 (10.0%) resulted in death, 22 (55.0%) required hospitalization, and 1 (2.5%) were considered life-threatening.

Is Off label use Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for REGORAFENIB\REGORAFENIB. However, 40 reports have been filed with the FAERS database.

What Other Side Effects Does REGORAFENIB\REGORAFENIB Cause?

Fatigue (18) Death (17) Asthenia (15) Diarrhoea (11) Decreased appetite (10) Pain in extremity (9) Palmar-plantar erythrodysaesthesia syndrome (9) Constipation (8) Dysphonia (7) Weight decreased (7)

What Other Drugs Cause Off label use?

RITUXIMAB (39,751) INFLIXIMAB (34,801) DENOSUMAB (34,612) METHOTREXATE (24,020) VEDOLIZUMAB (21,017) ETANERCEPT (20,178) TOCILIZUMAB (18,256) PREDNISONE (17,867) LENALIDOMIDE (17,017) ADALIMUMAB (16,417)

Which REGORAFENIB\REGORAFENIB Alternatives Have Lower Off label use Risk?

REGORAFENIB\REGORAFENIB vs RELATLIMAB REGORAFENIB\REGORAFENIB vs RELPAX REGORAFENIB\REGORAFENIB vs RELUGOLIX REGORAFENIB\REGORAFENIB vs REMDESIVIR REGORAFENIB\REGORAFENIB vs REMERON

Related Pages

REGORAFENIB\REGORAFENIB Full Profile All Off label use Reports All Drugs Causing Off label use REGORAFENIB\REGORAFENIB Demographics